Expired
TERM 1
March 11, 2020 · 2,258 days ago
🏥 Healthcare
On March 11, 2020, President Trump signed Memorandum 2020-05580 directing the Food and Drug Administration to allow manufacturers to produce general use respirators (non-medical masks and coverings) without prior approval. The memorandum removed regulatory barriers to expand respirator availability during the COVID-19 pandemic. This enabled broader civilian access to respiratory protection equipment during the early pandemic response.
Expired
TERM 1
March 11, 2020 · 2,258 days ago
🏥 Healthcare
On March 11, 2020, President Trump signed Proclamation 10578 suspending the entry of foreign nationals who had been physically present in designated countries within 14 days prior to entry into the United States, citing COVID-19 transmission risk. The proclamation applied restrictions to travelers from Iran, Italy, South Korea, and certain regions of China. The order affected travel to the United States for foreign nationals from these areas, while U.S. citizens and permanent residents were generally permitted entry with health screening.
Active
TERM 1
March 3, 2020 · 2,266 days ago
🏥 Healthcare
On March 3, 2020, President Trump signed a memorandum delegating authority to re-establish the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. The council had previously been allowed to expire and this action restored its establishment and operational authority. The council advises the federal government on strategies and policies related to antibiotic resistance, which affects treatment options for bacterial infections in Americans.
Expired
TERM 1
January 31, 2020 · 2,298 days ago
🏥 Healthcare
President Trump signed Proclamation 2020-02427 on January 31, 2020, designating February 2020 as American Heart Month. The proclamation calls for increased awareness of cardiovascular disease and encourages Americans to adopt healthier lifestyle practices. This is an annual proclamation with no binding regulatory effect on Americans.
Partially Undone
TERM 1
October 3, 2019 · 2,418 days ago
🏥 Healthcare
President Trump signed Executive Order 13890 on October 3, 2019, directing the Department of Health and Human Services to modify Medicare payment policies and drug pricing negotiations. The order instructed HHS to implement changes to Medicare payment rates for certain services and to advance drug price negotiations. The confirmed direct impact included modifications to Medicare reimbursement structures that affected healthcare provider payments and drug pricing mechanisms within the Medicare program.
Active
TERM 1
September 19, 2019 · 2,432 days ago
🏥 Healthcare
Executive Order 13887 was signed on September 19, 2019, directing federal agencies to modernize influenza vaccine development and manufacturing to improve effectiveness and reduce production timelines. The order established a task force to accelerate development of next-generation flu vaccines and streamline regulatory approval processes. The confirmed direct impact includes accelerated research funding and regulatory pathways for influenza vaccine innovation, though widespread deployment of modernized vaccines occurred after the order's implementation period.
Active
TERM 1
July 10, 2019 · 2,503 days ago
🏥 Healthcare
Executive Order 13879 was signed on July 10, 2019, directing federal agencies to increase access to kidney transplants and dialysis treatment options. The order established requirements for the Department of Health and Human Services to modify Medicare payment policies, expand home dialysis options, and streamline the organ transplant process. The confirmed effects include changes to Medicare reimbursement rates for dialysis providers and modifications to organ procurement and allocation standards affecting Americans with kidney disease.
Active
TERM 1
June 24, 2019 · 2,519 days ago
🏥 Healthcare
Executive Order 13877 was signed on June 24, 2019, requiring hospitals to publicly disclose standard charges for items and services, and requiring health insurers to disclose negotiated rates and out-of-pocket costs to patients. The order directed the Department of Health and Human Services to establish rules requiring price transparency. Confirmed effects include: hospitals began publishing price lists (though compliance varied and many lists remained difficult to access), and insurers incrementally increased availability of cost-estimation tools, though widespread patient access to negotiated rates was limited during the Trump administration.
Active
TERM 1
March 2019 · 2,603 days ago
🏥 Healthcare
The Trump administration backed tobacco companies in a regulatory dispute over e-cigarette flavoring rules, overruling FDA Commissioner Scott Gottlieb who resigned in protest. The decision favored industry interests that had donated substantially to Trump organizations over public health safeguards aimed at reducing youth vaping. The action weakened federal restrictions on flavored vaping products.
Active
TERM 1
April 1, 2019 · 2,603 days ago
🏥 Healthcare
On April 1, 2019, President Trump signed Proclamation 2019-06953 designating April 2, 2019 as World Autism Awareness Day. The proclamation recognized autism awareness and called for national observance of the day. As a proclamation, it carries no regulatory force and does not create new policy, programs, or funding.